Base: $176,600.00 to $294,300.00; bonus: 20% targe...
Hybrid
Global value and evidence generation strategy
Health economic modeling and cost-effectiveness analysis
Indirect treatment comparisons and network meta-analyses
This role drives optimal launch and patient access for Brepocitinib by generating robust value and evidence across its lifecycle
Job Summary
This role drives optimal launch and patient access for Brepocitinib by generating robust value and evidence across its lifecycle.
The Director will lead the development of global value narratives and evidence deliverables to support Health Technology Assessment submissions and payer decision-making.
Candidates must possess a graduate degree and significant experience in health economics research methods including cost-effectiveness models and real-world evidence studies.
Matching Summary
This role drives optimal launch and patient access for Brepocitinib by generating robust value and evidence across its lifecycle.
Salary
Base: $176,600.00 to $294,300.00; Bonus: 20% target of base salary; Benefits: 401(k) matching, paid vacation, medical/dental/vision coverage
Skills & Requirements
Must-have
Global value and evidence generation strategy
Health economic modeling and cost-effectiveness analysis
Indirect treatment comparisons and network meta-analyses
Real-world evidence study design and analysis
Patient-reported outcomes and quality-of-life measures
Nice-to-have
Experience with HTA organizations like NICE or ICER
Knowledge of Inflammation and Immunology therapeutic areas
Prior experience in alliance or co-development environments
Launch experience for late-stage assets
Strong collaboration skills in matrix organizations
Key Requirements
Graduate degree (MSc, MPH, PhD) required
7+ years experience with MSc/MPH/MBA or 5+ years with PharmD/PhD
Demonstrated depth in health services research methods and tools
Proven ability to manage complex projects with competing timelines
Must have permanent work authorization in the United States
Work Rights
Permanent work authorization in the United States required